Rankings
▼
Calendar
ALDX Q4 2025 Earnings — Aldeyra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ALDX
Aldeyra Therapeutics, Inc.
$318M
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$65,115
Operating Income
-$7M
Net Income
-$6M
EPS (Diluted)
$-0.11
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
$28.2T
Free Cash Flow
$28.2T
Stock-Based Comp.
-$3.6T
Balance Sheet
Total Assets
$72.1T
Total Liabilities
$27.8T
Stockholders' Equity
$44.3T
Cash & Equivalents
$70.0T
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$65,115
-$64,373
-1.2%
Operating Income
-$7M
-$17M
+59.8%
Net Income
-$6M
-$16M
+59.1%
← FY 2025
All Quarters